Market Cap | 7.65M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -369.97k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -6.00% |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
Dividend | N/A | Price/Book | 22.80 | EPS next 5Y | - | 52W High Chg | -48.00% |
Recommedations | - | Quick Ratio | 0.04 | Shares Outstanding | 364.98M | 52W Low Chg | 27.00% |
Insider Own | 41.81% | ROA | -49.17% | Shares Float | 217.43M | Beta | -0.02 |
Inst Own | 0.02% | ROE | -85.20% | Shares Shorted/Prior | -/- | Price | 0.02 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 64,406 | Target Price | - |
Oper. Margin | - | Earnings Date | Oct 16 | Volume | 135,000 | Change | 3.64% |
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing. It has a collaboration research agreement with the University of British Columbia. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
SMITH CLARENCE EDWARD | President & CEO President & CEO | Dec 26 | Buy | 0.015 | 7,333,334 | 110,000 | 58,547,777 | 12/28/23 |
Guzzetta Michael Richard | CFO CFO | Oct 26 | Buy | .0165 | 20,000 | 330 | 736,369 | 10/27/23 |
SMITH CLARENCE EDWARD | President & CEO President & CEO | Jan 23 | Buy | 0.02 | 2,000,000 | 40,000 | 43,964,443 | 01/31/23 |
SMITH CLARENCE EDWARD | President & CEO President & CEO | Dec 14 | Buy | 0.03 | 2,187,489 | 65,625 | 41,964,443 | 01/04/23 |
SMITH CLARENCE EDWARD | President & CEO President & CEO | Jul 11 | Buy | 0.03 | 2,666,667 | 80,000 | 34,261,110 | 07/14/22 |
SMITH CLARENCE EDWARD | President & CEO President & CEO | Mar 30 | Buy | 0.05 | 600,000 | 30,000 | 31,594,443 | 04/14/22 |
Guzzetta Michael Richard | CFO CFO | Jun 28 | Option | 0.07 | 555,556 | 38,889 | 728,869 | 06/28/21 |
Guzzetta Michael Richard | CFO CFO | Jun 28 | Sell | 0.22 | 27,500 | 6,050 | 701,369 | 06/28/21 |